Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway

References

• Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: mechanistic and clinical aspects. World J Gastroenterol. 2019;25(5):521–538.
   PubMedGoogle Scholar
• Chen L, Brenner DA, Kisseleva T. Combatting fibrosis: exosome-based therapies in the regression of liver fibrosis. Hepatol Commun. 2019;3(2):180–192.
   PubMed Web of Science ®Google Scholar
• Liu Y-M, Cong S, Cheng Z, et al. Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway. Eur J Pharmacol. 2020;876:172946.
   PubMedGoogle Scholar
• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151–166.
   PubMed Web of Science ®Google Scholar
• Connolly G, Li Z, Young M, et al. P5000 Wnt/b-catenin signalling drives angiotensin II induced cardiac fibrosis via WISP-1. Eur Heart J. 2019;40(Supplement_1):0178. ehz746.
   Google Scholar
• Wang X, Dai W, Wang Y, et al. Blocking the Wnt/β-catenin pathway by lentivirus-mediated short hairpin RNA targeting β-catenin gene suppresses silica-induced lung fibrosis in mice. Int J Environ Res Public Health. 2015;12(9):10739–10754.
   PubMedGoogle Scholar
• Feng Y, Ren J, Gui Y, et al. Wnt/β-catenin-promoted macrophage alternative activation contributes to kidney fibrosis. J Am Soc Nephrol. 2018;29(1):182–193.
   PubMed Web of Science ®Google Scholar
• Cui L, Jia X, Zhou Q, et al. Curcumin affects β-catenin pathway in hepatic stellate cell in vitro and in vivo. J Pharm Pharmacol. 2014;66(11):1615–1622.
   PubMedGoogle Scholar
• Akhtar T, Sheikh N. An overview of thioacetamide-induced hepatotoxicity. Toxin Rev. 2013;32(3):43–46.
   Web of Science ®Google Scholar
• Salama SM, Abdulla MA, AlRashdi AS, et al. Mechanism of hepatoprotective effect of Boesenbergia rotunda in thioacetamide-induced liver damage in rats. Evid-Based Complement Alternat Med. 2013;2013:1–13.
   Web of Science ®Google Scholar
• Sundarraj K, Raghunath A, Perumal E. A review on the chemotherapeutic potential of fisetin: in vitro evidences. Biomed Pharmacother. 2018;97:928–940.
   PubMed Web of Science ®Google Scholar
• Naeimi AF, Alizadeh M. Antioxidant properties of the flavonoid fisetin: an updated review of in vivo and in vitro studies. Trends Food Sci Technol. 2017;70:34–44.
   Web of Science ®Google Scholar
• Zhang L, Tong X, Huang J, et al. Fisetin alleviated bleomycin-induced pulmonary fibrosis partly by rescuing alveolar epithelial cells from senescence. Front Pharmacol. 2020;11:553690.
   PubMedGoogle Scholar
• Xu M, Ge C, Qin Y, et al. Activated TNF-α/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: inhibition by dietary fisetin intervention. Food Funct. 2019;10(3):1302–1316.
   PubMed Web of Science ®Google Scholar
• Gillessen A, Schmidt HH-J. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37(4):1279–1301.
   PubMed Web of Science ®Google Scholar
• Tighe SP, Akhtar D, Iqbal U, et al. Chronic liver disease and silymarin: a biochemical and clinical review. J Clin Transl Hepatol. 2020;8(4):454–458.
   PubMedGoogle Scholar
• El-Baz FK, Salama AA, Hussein RA. Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats. Toxicol Rep. 2020;7:36–45.
   PubMedGoogle Scholar
• Ren Q, Tao S, Guo F, et al. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Phytomedicine. 2021;87:153552.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Theory and practice of histological techniques. London, England: Churchill Livingstone; 2008.
   Google Scholar
• Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29(4):577–580.
   PubMed Web of Science ®Google Scholar
• Berumen J, Baglieri J, Kisseleva T, et al. Liver fibrosis: pathophysiology and clinical implications. WIREs Mech Dis. 2021;13(1):e1499.
   PubMedGoogle Scholar
• Eissa LA, Kenawy HI, El-Karef A, et al. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91–100.
   PubMed Web of Science ®Google Scholar
• Bulle F, Mavier P, Zafrani ES, et al. Mechanism of gamma-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach. Hepatology. 1990;11(4):545–550.
   PubMed Web of Science ®Google Scholar
• El-Magd NFA, El-Karef A, El-Shishtawy MM, et al. Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on nuclear factor-kappa B pathway in thioacetamide-induced fibrosis in rats. Egypt J Basic Appl Sci. 2015;2(2):65–74.
   Google Scholar
• Zhao L, Zhang J, Pan L, et al. Protective effect of 7, 3′, 4′-flavon-3-ol (fisetin) on acetaminophen-induced hepatotoxicity in vitro and in vivo. Phytomedicine. 2019;58:152865.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao L, Hu C, et al. Fisetin prevents acetaminophen-induced liver injury by promoting autophagy. Front Pharmacol. 2020;11:162.
   PubMed Web of Science ®Google Scholar
• Jayakumar M, Subramanian P. Chronotherapeutic influence of fisetin on ammonium chloride-induced hyperammonemic rats. Biol Rhythm Res. 2013;44(4):577–588.
   Web of Science ®Google Scholar
• Jalali SM, Najafzadeh H, Bahmei S. Protective role of silymarin and D-penicillamine against lead-induced liver toxicity and oxidative stress. Toxicol Ind Health. 2017;33(6):512–518.
   PubMedGoogle Scholar
• Sukalingam K, Ganesan K, Xu B. Protective effect of aqueous extract from the leaves of Justicia tranquebariesis against thioacetamide-induced oxidative stress and hepatic fibrosis in rats. Antioxidants. 2018;7(7):78.
   Web of Science ®Google Scholar
• Lee YH, Son JY, Kim KS, et al. Estrogen deficiency potentiates thioacetamide-induced hepatic fibrosis in Sprague–Dawley rats. IJMS. 2019;20(15):3709.
   Google Scholar
• Althunibat OY, Al Hroob AM, Abukhalil MH, et al. Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy. Life Sci. 2019;221:83–92.
   PubMed Web of Science ®Google Scholar
• Ali AM, El-Tawil OS, Al-Mokaddem AK, et al. Promoted inhibition of TLR4/miR-155/NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. Chem Biol Interact. 2021;336:109398.
   PubMedGoogle Scholar
• Fielding CA, Jones GW, McLoughlin RM, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40(1):40–50.
   PubMed Web of Science ®Google Scholar
• Yang YM, Seki E. TNFα in liver fibrosis. Curr Pathobiol Rep. 2015;3(4):253–261.
   PubMedGoogle Scholar
• Elnfarawy AA, Nashy AE, Abozaid AM, et al. Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Hum Exp Toxicol. 2021;40(2):355–368.
   PubMedGoogle Scholar
• Zhang H-F, Zhang H-B, Wu X-P, et al. Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling. Acta Pharmacol Sin. 2020;41(10):1348–1356.
   PubMedGoogle Scholar
• Hu L-F, Feng J, Dai X, et al. Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling. J Nutr Biochem. 2020;77:108253.
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad signaling pathways of the TGF-β family. Cold Spring Harb Perspect Biol. 2017;9(2):a022129.
   PubMedGoogle Scholar
• El-Mihi KA, Kenawy HI, El-Karef A, et al. Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K/akt pathway. Life Sci. 2017;187:50–57.
   PubMed Web of Science ®Google Scholar
• Hsieh Y-C, Lee K-C, Lei H-J, et al. Pro-renin receptor knockdown attenuates liver fibrosis through inactivation of ERK/TGF-β1/SMAD3 pathway. Cell Mol Gastroenterol Hepatol. 2021;12(3):813–838.
   PubMedGoogle Scholar
• Bansal R, Nagórniewicz B, Prakash J. Clinical advancements in the targeted therapies against liver fibrosis. Mediators Inflamm. 2016;2016:7629724.
   PubMedGoogle Scholar
• Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochim Biophys Acta. 2013;1832(7):876–883.
   PubMed Web of Science ®Google Scholar
• El-Baz FK, Salama A, Ali SI, et al. Haematococcus pluvialis carotenoids enrich fractions ameliorate liver fibrosis induced by thioacetamide in rats: modulation of metalloproteinase and its inhibitor. Biomed Res Int. 2021;2021:6631415.
   PubMed Web of Science ®Google Scholar
• Sun J, Wu Y, Long C, et al. Anthocyanins isolated from blueberry ameliorates CCl4 induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice. Food Chem Toxicol. 2018;120:491–499.
   PubMedGoogle Scholar
• Agioutantis PC, Kotsikoris V, Kolisis FN, et al. RNA-seq data analysis of stimulated hepatocellular carcinoma cells treated with epigallocatechin gallate and fisetin reveals target genes and action mechanisms. Comput Struct Biotechnol J. 2020;18:686–695.
   PubMedGoogle Scholar
• Choi M-S, Choi J-Y, Kwon E-Y. Fisetin alleviates hepatic and adipocyte fibrosis and insulin resistance in diet-induced obese mice. J Med Food. 2020;23(10):1019–1032.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu X-Q, Sun H-N, et al. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1. Int Immunopharmacol. 2018;63:183–190.
   PubMed Web of Science ®Google Scholar
• Ying J, Li H, Yu J, et al. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res. 2008;14(1):55–61.
   PubMed Web of Science ®Google Scholar
• Koehler A, Schlupf J, Schneider M, et al. Loss of xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. Dev Biol. 2013;383(1):132–145.
   PubMedGoogle Scholar
• Nishikawa K, Osawa Y, Kimura K. Wnt/β-catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs. IJMS. 2018;19(10):3103.
   Google Scholar
• Li T, Zhang L, Huo X. Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt/β-catenin signaling pathway. Oncol Lett. 2018;15(5):7118–7122.
   PubMedGoogle Scholar
• Li L-y, Yang C-C, Yang J-F, et al. ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway. Eur J Pharmacol. 2019;865:172787.
   PubMedGoogle Scholar
• Ma B, van Blitterswijk CA, Karperien MA. A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum. 2012;64(8):2589–2600.
   PubMedGoogle Scholar
• Abd Elhameed AG, Helal MG, Said E, et al. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: a novel suppressive impact on Wnt/hedgehog/Notch1 signaling. Environ Toxicol Pharmacol. 2021;86:103668.
   PubMedGoogle Scholar
• Abdel-Bakky M, Helal G, El-Sayed E, et al. Silencing of tissue factor by antisense deoxyoligonucleotide mitigates thioacetamide-induced liver injury. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(10):1887–1898.
   PubMedGoogle Scholar
• Syed DN, Afaq F, Maddodi N, et al. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J Invest Dermatol. 2011;131(6):1291–1299.
   PubMedGoogle Scholar
• Agraval H, Yadav UC. MMP-2 and MMP-9 mediate cigarette smoke extract-induced epithelial–mesenchymal transition in airway epithelial cells via EGFR/akt/GSK3β/β-catenin pathway: amelioration by fisetin. Chem Biol Interact. 2019;314:108846.
   PubMed Web of Science ®Google Scholar
• Liang Y, Kong D, Zhang Y, et al. Fisetin inhibits cell proliferation and induces apoptosis via JAK/STAT3 signaling pathways in human thyroid TPC 1 cancer cells. Biotechnol Bioproc E. 2020;25(2):197–205.
   Google Scholar
• Vaid M, Prasad R, Sun Q, et al. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One. 2011;6(7):e23000.
   PubMedGoogle Scholar